Gut microbiome samples from the AtezoTRIBE phase-II clinical trial
Shotgun metagenomic stool samples for the AtezoTRIBE phase-II randomized trial which was established to study the impact of the atezolizumab immune therapy treatment to folfoxiri plus bevacizumab treatment in unresectable metastatic colorectal cancer (CRC) patients.